CXCR3 chemokine receptor-plasma IP10 interaction in patients with coronary artery disease

Circulation Journal

Volumn 67, Issue 10, 2003, Pages 851-854

  Kawamura, Akira ^a   Miura, Shin Ichiro ^a   Fujino, Masahiro ^a   Nishikawa, Hiroaki ^a   Matsuo, Yoshino ^a   Tanigawa, Hiroaki ^a   Tomita, Sayo ^a   Tsuchiya, Yoshihiro ^a   Matsuo, Kunihiro ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Coronary artery disease; CXCR3; Interferon inducible protein 10; Restenosis

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEART CATHETERIZATION; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; SIGNAL TRANSDUCTION; STENOSIS; VASCULAR DISEASE;

AGED; CASE-CONTROL STUDIES; CHEMOKINES, CXC; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; PROTEIN BINDING; RECEPTORS, CHEMOKINE; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 10744229936     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.851     Document Type: Article

References (19)

1. Mackay CR. Chemokines: Immunology's high impact factors. Nat Immunol 2001; 2: 95-101.
2. Zlotnik A, Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity 2000; 12: 121-127.
3. Cipollone F, Marini M, Fazia M. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001; 21: 327-334.
4. Horvath C, Welt FGP, Nedelman M. Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: Inhibitory potential depends on type of injury and leukocytes targeted. Circ Res 2002; 90: 488-494.
5. Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993; 177: 1809-1814.
6. Melter M, Exeni A. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001; 104: 2558-2564.
7. Horiguchi K, Kitagawa-Sakakida S, Sawa Y, Li ZZ, Fukushima N, Shirakura R, et al. Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy. J Heart Lung Transplant 2002; 21: 1090-1100.
8. Saku K, Zhang B, Ohta T, Arakawa k. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis. J Am Coll Cardiol 1999; 33: 436-443.
9. Libby P, Schwartz D. A cascade model for restenosis: A special case of atherosclerosis progression. Circulation 1992; 86(Suppl III): III-47-III-52.
10. Moser B, Loetscher M, Piali L, Loestcher P. Lymphocyte responses to chemokines. Intern Rev Immunol 1998; 16: 323-344.
11. Hoffmann R, Mintz GS. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.
12. Rollins BJ. Chemokines. Blood 1997; 90: 909-928.
13. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995; 91: 2995-3001.
14. Rogers C, Welt FG, Karnovsky MJ, Edelman ER. Monocyte recruitment and neointimal hyperplasia in rabbits: Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol 1996; 16: 1312-1318.
15. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. Instent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224-230.
16. Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE. Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistochemical analyses. Circulation 1998; 98: 224-233.
17. Oshima S, Ogawa H, Hokimoto S, Nakamura S, Noda K, Saito T, et al. Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implantation. Jpn Circ J 2001; 65: 261-264.
18. Hokimoto S, Oike Y, Saito T, Kitaoka M, Oshima S, Noda K, et al. Increased expression of monocyte chemoattractant protein-1 in atherectomy specimens from patients with restenosis after percutaneous transluminal coronary angioplasty. Circ J 2002; 66: 114-116.
19. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99: 44-52.